共查询到18条相似文献，搜索用时 46 毫秒
1.
本研究旨在考察肿节风三清颗粒的抗炎和平喘作用。MTT法检测200、400、800、1 600 μg/mL肿节风三清颗粒对RAW264.7细胞活力的影响;用脂多糖（LPS）诱导RAW264.7细胞建立体外炎症模型,并采用400、800、1 600 μg/mL肿节风三清颗粒处理,ELISA法检测细胞上清液中肿瘤坏死因子α（TNF-α）、白细胞介素-6（IL-6）水平;用卵清蛋白（OVA）致敏、激发雌性BALB/c小鼠建立哮喘模型,并采用100、200、300 mg/kg肿节风三清颗粒处理,末次激发24 h后,测定哮喘小鼠气道高反应性（AHR）,取支气管肺泡灌洗液（BALF）进行白细胞分类计数,ELISA法检测BALF中IL-4、IL-5和IL-13浓度及血清中OVA-IgE水平。结果显示,200~16 00 μg/mL肿节风三清颗粒对RAW 264.7细胞增殖有显著或极显著促进作用（P<0.05;P<0.01）,与LPS组相比,800、1 600 μg/mL肿节风三清颗粒能够极显著降低TNF-α和IL-6水平（P<0.01）;与哮喘模型组相比,肿节风三清颗粒明显改善了气道高反应性,明显减少了BALF中的炎症细胞数目及IL-4、IL-5和IL-13浓度,极显著降低了血清中OVA-IgE水平（P<0.01）。综上所述,肿节风三清颗粒可通过抑制炎症因子的表达对炎症细胞模型和哮喘小鼠模型起到良好的保护作用。 相似文献
2.
肿节风三清颗粒抗炎和抗哮喘作用 总被引：1，自引：1，他引：0
本研究旨在考察肿节风三清颗粒的抗炎和平喘作用。MTT法检测200、400、800、1 600μg/mL肿节风三清颗粒对RAW264.7细胞活力的影响;用脂多糖(LPS)诱导RAW264.7细胞建立体外炎症模型,并采用400、800、1 600μg/mL肿节风三清颗粒处理,ELISA法检测细胞上清液中肿瘤坏死因子α(TNF-α)、白细胞介素-6(IL-6)水平;用卵清蛋白(OVA)致敏、激发雌性BALB/c小鼠建立哮喘模型,并采用100、200、300mg/kg肿节风三清颗粒处理,末次激发24h后,测定哮喘小鼠气道高反应性(AHR),取支气管肺泡灌洗液(BALF)进行白细胞分类计数,ELISA法检测BALF中IL-4、IL-5和IL-13浓度及血清中OVA-IgE水平。结果显示,200~16 00μg/mL肿节风三清颗粒对RAW 264.7细胞增殖有显著或极显著促进作用(P0.05;P0.01),与LPS组相比,800、1 600μg/mL肿节风三清颗粒能够极显著降低TNF-α和IL-6水平(P0.01);与哮喘模型组相比,肿节风三清颗粒明显改善了气道高反应性,明显减少了BALF中的炎症细胞数目及IL-4、IL-5和IL-13浓度,极显著降低了血清中OVA-IgE水平(P0.01)。综上所述,肿节风三清颗粒可通过抑制炎症因子的表达对炎症细胞模型和哮喘小鼠模型起到良好的保护作用。 相似文献
3.
迷迭香酸对哮喘小鼠氧化性肺损伤的保护作用 总被引：1，自引：0，他引：1
为评价迷迭香酸对哮喘小鼠模型氧化性肺损伤的保护作用,本研究用卵清蛋白（OVA）致敏、激发雌性BALB/c小鼠建立哮喘模型,并用OVA和H2O2联合激发小鼠作为氧化肺损伤阳性对照模型。在最后一次滴鼻激发24 h后,取支气管肺泡灌洗液（BALF）进行细胞计数并测定活性氧（ROS）、超氧化物歧化酶（SOD）和谷胱甘肽过氧化物酶（GSH-Px）水平,取左侧肺脏固定做HE染色。结果显示,迷迭香酸可明显减少BALF中细胞总数和嗜酸性粒细胞数目,显著抑制肺组织和BALF中ROS的产生,升高SOD和GSH-Px水平,改善肺组织病理变化。本试验结果表明,迷迭香酸对氧化肺损伤起到明显的保护作用。 相似文献
4.
5.
6.
试验旨在探究UBC13蛋白对支气管哮喘小鼠体内Th2、Th17细胞极化的影响。18只BALB/c小鼠随机均分为3组：PBS组、哮喘模型（OVA）组和UBC13蛋白（UBC13）组,OVA组和UBC13组采用卵清蛋白（OVA）和脂多糖（LPS）进行致敏和雾化建立哮喘模型,其中UBC13组于每次雾化前0.5 h腹腔注射100 μg UBC13蛋白。末次雾化激发24 h后处死小鼠,采集样品,通过HE染色观察肺脏切片病理学变化、PAS染色观察气道黏液的分泌,ELISA法检测血清IgE浓度和肺支气管肺泡灌洗液（BALF）上清中IL-4、IL-5和IL-17A的水平,实时荧光定量PCR法检测肺脏Th2型相关因子IL-4、IL-5、IL-13、IFN-γ mRNA和Th17型细胞因子IL-1β、IL-6、IL-17A、IL-23 mRNA的相对表达量。结果显示,试验成功建立了哮喘模型,与PBS组相比,OVA组IgE浓度极显著上升（P < 0.01）,肺脏病理切片炎性细胞浸润和中性黏液分泌现象明显,肺脏中IL-1β、IL-4、IL-6、IL-13和IL-17A mRNA相对表达量均极显著升高（P < 0.01）,IL-5和IL-23 mRNA相对表达量显著升高（P < 0.05）,IFN-γ mRNA相对表达量极显著下降（P < 0.01）,BALF中IL-4、IL-5和IL-17A的水平极显著上升（P < 0.01）;与OVA组相比,UBC13组IgE浓度显著降低（P < 0.05）,病理切片炎性细胞浸润现象减轻、黏液分泌减少,肺脏IL-1β、IL-4、IL-17A、IL-13和IL-23 mRNA相对表达量均显著下降（P < 0.05）,IFN-γ mRNA相对表达量显著升高（P<0.05）;IL-6 mRNA相对表达量极显著下降（P < 0.01）,BALF中IL-5的水平极显著下降（P < 0.01）,IL-4的水平显著下降（P < 0.05）,IL-17A的水平无显著差异（P > 0.05）。由此可见,UBC13蛋白能下调Th2和Th17型细胞因子的表达量,影响哮喘模型Th2和Th17细胞的极化。 相似文献
7.
8.
为探讨漏芦醇提物（RUEE）对脂多糖（LPS）诱导的小鼠乳腺上皮细胞（HC11细胞）的抗炎作用及机制,试验利用RUEE(80μg/mL)、LPS(1μg/mL)单独处理以及RUEE(80μg/mL)+LPS(1μg/mL)共处理HC11细胞,采用荧光定量PCR检测炎性细胞因子及Toll样受体4(TLR4)mRNA表达水平,采用Western blotting检测核转录因子κB(NF-κB)通路关键因子的蛋白表达量。结果表明：LPS诱导可明显提高HC11细胞肿瘤坏死因子-α(TNF-α)、环氧合酶-2(COX-2)、白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)的mRNA表达水平（P<0.05）;明显上调TLR4 mRNA表达及NF-κB p65和NF-κB抑制蛋白α(IκBα)的磷酸化水平（P<0.05）。RUEE预处理可显著降低LPS诱导的HC11细胞TNF-α、COX-2、IL-6、IL-1β的mRNA表达（P<0.05）;显著下调TLR4 mRNA表达及NF-κB p65和IκBα的磷酸化水平（P<0.05）。由此可知漏芦醇提物可通过抑制TLR... 相似文献
9.
本试验旨在研究脂多糖(LPS)刺激条件下人参多糖(GPS)对小鼠单核巨噬细胞形态及免疫功能的调节作用。采用LPS刺激小鼠巨噬细胞(RAW264.7),通过测量不同浓度(1、0.5、0.1 mg/mL)GPS对细胞形态、生物酶活性、促炎症因子分泌及TLR4/NF-κB信号通路mRNA表达量的影响来研究不同浓度的GPS对LPS引起小鼠巨噬细胞免疫应激的调控作用。结果表明:添加GPS能抑制由LPS引起的细胞形态和细胞增殖能力的变化;1 mg/mL GPS能够显著提高巨噬细胞酸性磷酸酶的活性;0.5、1 mg/mL GPS能够显著缓解由LPS刺激引起的碱性磷酸酶活性的降低;不同浓度GPS均能显著降低由LPS诱导的促炎症因子IL-1β、TNF-α水平;LPS刺激显著提高巨噬细胞TLR4、MyD88、NF-κB的mRNA表达量,而添加GPS后,巨噬细胞TLR4、MyD88、NF-κB的mRNA表达量均表现出不同程度降低(P<0.05)。结果显示,添加GPS可以改善细胞形态,恢复细胞增殖能力,GPS可通过调节TLR4/NF-κB信号通路降低促炎症因子IL-1β和TNF-α的分泌及表达,减少机体免疫应激反应。 相似文献
10.
通过构建的细菌脂多糖（LPS）诱导小鼠巨噬细胞（RAW-264.7）的体外炎症模型,研究了不同质量浓度甲基-戈米辛O对肿瘤坏死因子（TNF-α）、白介素-1β（IL-1β）、IL-6和IL-10合成的影响,以及对NF-κB和MAPK信号转导通路的作用。结果显示,0.5、2.5、12.5mg/L甲基-戈米辛O能显著抑制RAW-264.7合成的TNF-α和IL-6,但是对IL-1β和IL-10无显著调节作用。甲基-戈米辛O以剂量依赖的方式显著抑制了LPS对NF-κB和丝裂原活化蛋白激酶（Mitogen-activated protein kinase,MAPK）的激活作用。结果表明,甲基-戈米辛O可能通过NF-κB和MAPK这条通路发挥抗炎作用。 相似文献
11.
12.
Hughes KJ Nicolson L Da Costa N Franklin SH Allen KJ Dunham SP 《Veterinary immunology and immunopathology》2011,140(1-2):82-89
Inflammatory airway disease (IAD) is a common disorder of performance horses and is associated with poor performance and accumulation of mucus and inflammatory cells in lower airway secretions. Horses with IAD frequently have increased relative counts of neutrophils in bronchoalveolar lavage fluid (BALF); less commonly relative counts of eosinophils and/or mast cells may be increased. The aetiopathogenesis of IAD is unknown and may involve innate and/or acquired immune responses to various factors including respirable dust constituents, micro-organisms, noxious gases and unconditioned air. The molecular pathways and role of the immune system in the pathogenesis of IAD remain poorly defined and it is unknown whether polarised T cell responses occur in the disease, as have been reported to occur in equine recurrent airway obstruction and asthma in humans. Elucidating cytokine responses that develop in horses with IAD may allow a greater understanding of the possible aetiopathological pathway(s) involved and could contribute to development of novel treatments. We compared the mRNA expression of tumour necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), interleukin (IL)-1β, IL-2, IL-4, IL-8, IL-13, IL-17 and IL-23 in cell pellets extracted from BALF of horses with IAD (n=21) and horses free of respiratory tract disease (n=17). Horses with IAD had significantly increased levels of TNF-α, IL-1β and IL-23 mRNA; no significant differences in the other cytokine mRNAs were detected. The results of this study indicate that IAD of horses is associated with increased mRNA expression of pro-inflammatory cytokines in BALF cells, which may reflect stimulation of the innate immune responses to inhaled antigens. There was no evidence of a polarised T-cell cytokine response suggesting hypersensitivity responses may not be involved in the aetiopathogenesis of IAD. 相似文献
13.
Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma 总被引：2，自引：0，他引：2
Reinero CR Cohn LA Delgado C Spinka CM Schooley EK DeClue AE 《Veterinary immunology and immunopathology》2008,121(3-4):241-250
Allergic asthma is driven by relative overexpression of Th2 cell-derived cytokines in response to aeroallergens. In independent studies, both allergen-specific rush immunotherapy (RIT) and CpG oligodeoxynucleotides (ODN) showed promise in blunting eosinophilic inflammation in a model of feline allergic asthma. We hypothesized that RIT using allergen and CpG ODN would work synergistically to dampen the asthmatic phenotype in experimentally asthmatic cats. Twelve cats with asthma induced using Bermuda grass allergen (BGA) were studied. Of these, six were administered adjuvanted BGA RIT using CpG ODN #2142; six were administered placebo (saline) RIT and later crossed over to adjuvanted RIT. Over 2 days, subcutaneous CpG ODN (0.5ng/kg) with BGA (increasing doses every 2h from 20 to 200microg) was administered. Adverse events were recorded and compared with historical controls. Percentage of eosinophils in bronchoalveolar lavage fluid (BALF), % peripheral CD4+CD25+ T regulatory cells (Tregs), lymphocyte proliferation in response to ConA, and cytokine concentrations in BALF were measured over 2 months. Group mean BALF % eosinophils for the adjuvanted RIT cats were significantly lower at week 1 and month 1 (p=0.03 for both), and marginally significantly lower at month 2 (p=0.09) compared with placebo RIT cats. By the end of the study, 8/12 treated cats had BALF % eosinophils within the reference range for healthy cats. Adjuvanted RIT, but not placebo RIT, cats had significant decreases in the ConA stimulation index over time (p=0.05). BALF IL-4 concentrations were significantly higher at week 1 in adjuvanted RIT cats compared with baseline and month 2, and also with placebo RIT cats at week 1. No significant differences were detected between treatments or over time for IL-10 or IFN-gamma concentrations in BALF or for %Tregs cells in peripheral blood. Adjuvanted RIT using CpG ODN in experimental feline asthma dampens eosinophilic airway inflammation. Adverse effects associated with adjuvanted RIT were less severe compared with a historical, non-adjuvanted RIT protocol. The exact mechanism(s) by which adjuvanted RIT alters the aberrant allergic immune response were not elucidated in this study. 相似文献
14.
Reinero CR Decile KC Byerly JR Berghaus RD Walby WE Berghaus LJ Hyde DM Schelegle ES Gershwin LJ 《American journal of veterinary research》2005,66(7):1121-1127
OBJECTIVE: To compare the effects of an orally administered corticosteroid (prednisone), an inhaled corticosteroid (flunisolide), a leukotriene-receptor antagonist (zafirlukast), an antiserotonergic drug (cyproheptadine), and a control substance on the asthmatic phenotype in cats with experimentally induced asthma. ANIMALS: 6 cats with asthma experimentally induced by the use of Bermuda grass allergen (BGA). PROCEDURES: A randomized, crossover design was used to assess changes in the percentage of eosinophils in bronchoalveolar lavage fluid (BALF); airway hyperresponsiveness; blood lymphocyte phenotype determined by use of flow cytometry; and serum and BALF content of BGA-specific IgE, IgG, and IgA determined by use of ELISAs. RESULTS: Mean +/- SE eosinophil percentages in BALF when cats were administered prednisone (5.0 +/- 2.3%) and flunisolide (2.5 +/- 1.7%) were significantly lower than for the control treatment (33.7 +/- 11.1%). We did not detect significant differences in airway hyperresponsiveness or lymphocyte surface markers among treatments. Content of BGA-specific IgE in serum was significantly lower when cats were treated with prednisone (25.5 +/- 5.4%), compared with values for the control treatment (63.6 +/- 12.9%); no other significant differences were observed in content of BGA-specific immunoglobulins among treatments. CONCLUSIONS AND CLINICAL RELEVANCE: Orally administered and inhaled corticosteroids decreased eosinophilic inflammation in airways of cats with experimentally induced asthma. Only oral administration of prednisone decreased the content of BGA-specific IgE in serum; no other significant local or systemic immunologic effects were detected among treatments. Inhaled corticosteroids can be considered as an alternate method for decreasing airway inflammation in cats with asthma. 相似文献
15.
Schooley EK McGee Turner JB Jiji RD Spinka CM Reinero CR 《American journal of veterinary research》2007,68(11):1265-1271
OBJECTIVE: To determine whether oral administration of cyproheptadine or cetirizine blocks the action of serotonin and histamine, respectively, and results in diminished eosinophilic airway inflammation in cats with experimentally induced asthma. ANIMALS: 9 cats in which asthma was experimentally induced through exposure to Bermuda grass allergen (BGA) during a 3-month period. PROCEDURES: Cats were randomized to receive monotherapy with each of 3 treatments for 1 week: placebo (flour in a gelatin capsule, PO, q 12 h), cyproheptadine (8 mg, PO, q 12 h), or cetirizine (5 mg, PO, q 12 h). A 1-week washout period was allowed to elapse between treatments. Prior to and following each 1-week treatment period, blood and bronchoalveolar lavage fluid (BALF) samples were collected. The percentage of eosinophils in BALF was evaluated to determine treatment efficacy. Serum and BALF BGA-specific immunoglobulin contents and plasma and BALF histamine concentrations were determined via ELISAs. Plasma and BALF serotonin concentrations were measured by use of a fluorometric method. RESULTS: The mean +/- SD percentage of eosinophils in BALF did not differ significantly among treatment groups (placebo, 40 +/- 22%; cyproheptadine, 27 +/- 16%; and cetirizine, 31 +/- 20%). Among the treatment groups, BGA-specific immunoglobulin content and histamine and serotonin concentrations were not significantly different. CONCLUSIONS AND CLINICAL RELEVANCE: In cats with experimentally induced asthma, cyproheptadine and cetirizine were not effective in decreasing airway eosinophilic inflammation or in altering several other measured immunologic variables. Neither cyproheptadine nor cetirizine can be advocated as monotherapy for cats with allergen-induced asthma. 相似文献
16.
DeLuca L Erb HN Young JC Perkins GA Ainsworth DM 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2008,22(2):427-435
BACKGROUND: Chemokine expression in airway epithelium and bronchoalveolar lavage fluid (BALF) cells of horses with recurrent airway obstruction (RAO) is increased. HYPOTHESIS: For RAO-affected horses that are stabled and fed a pelleted ration, the addition of oral dexamethasone further improves pulmonary function and reduces inflammatory gene expression in pulmonary cells. ANIMALS: Twelve RAO-affected horses. METHODS: In a randomized cross-over experiment, the effect of feeding pellets in lieu of hay to stabled, RAO-affected horses was compared with the effect of feeding pellets and administering a 21-day decreasing dose regimen of oral dexamethasone on the expression (by kinetic polymerase chain reaction) of interleukin-8 (IL-8), chemokine (C-X-C motif) ligand 2 (CXCL2), IL-1beta, IL-6, and beta-actin in the BALF cells and of IL-8, CXCL2, 2 IL-1 receptor (IL-1R2), Toll-like receptor 4 (TLR4), and glyceraldehyde 3-phosphate dehydrogenase in the bronchial epithelium 2 days after the final dose. RESULTS: Both treatments reduced airway neutrophilia and breathing efforts but the addition of dexamethasone was associated with fewer treatment failures. Compared with feed changes alone, dexamethasone administration further reduced the expression of IL-8, CXCL2, and IL-1beta in the BALF cells 3.3-, 2.5-, and 4.7-fold, respectively. In the airway epithelium, both treatments were equally efficacious in reducing the expression of IL-8 and CXCL2 expression relative to pretreatment values, but either treatment failed to alter the expression of IL-1R2 and TLR4. CONCLUSIONS AND CLINICAL IMPORTANCE: For a rapid and consistent improvement in pulmonary function and a reduction in inflammatory gene expression of the BALF cells, a decreasing dose of oral dexamethasone in combination with feed alterations is more efficacious for horses that must remain stabled. 相似文献
17.
《Journal of Equine Veterinary Science》2004,24(1):29-36
18.
Asthma is a chronic inflammatory lung disease of the airway; the incidence and prevalence of asthma remain high worldwide. Astragaloside IV (AS‐IV) is the main active constituent of Astragalus membranaceus. Accumulating evidence suggests that AS‐IV possesses anti‐inflammatory and anti‐asthmatic ability, but the potential molecular mechanism is required to further clarify. In this study, the anti‐asthmatic effects of AS‐IV on mice with ovalbumin (OVA)‐induced allergic inflammation were analysed. We analysed airway hyperresponsiveness (AHR), numbers of inflammatory cells, inflammation situation in lung tissue and cytokines level in bronchoalveolar lavage fluid (BALF) between OVA‐induced mice with and without AS‐IV treatment. Moreover, we explored the possible signalling pathway behind the anti‐asthmatic effects. Our results revealed that AS‐IV treatment ameliorates airway inflammation and AHR in an OVA‐induced asthma model. Besides, AS‐IV treatment inhibits the interleukin (IL)‐4, ‐5 and ‐13 production, and further study indicated that AS‐IV treatment downregulates the expression level of p‐JAK2/p‐STAT6 proteins. Taken together, the present study suggested that the inhibitory effects of AS‐IV on asthma therapy are at least partially involved in inhibiting the JAK2/STAT6 signalling pathway. 相似文献